NM_000487.6:c.1447G>T
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_000487.6(ARSA):c.1447G>T(p.Glu483*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,457,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000487.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- metachromatic leukodystrophyInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- metachromatic leukodystrophy, juvenile formInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000487.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARSA | NM_000487.6 | MANE Select | c.1447G>T | p.Glu483* | stop_gained | Exon 8 of 8 | NP_000478.3 | ||
| ARSA | NM_001085425.3 | c.1447G>T | p.Glu483* | stop_gained | Exon 9 of 9 | NP_001078894.2 | |||
| ARSA | NM_001085426.3 | c.1447G>T | p.Glu483* | stop_gained | Exon 9 of 9 | NP_001078895.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARSA | ENST00000216124.10 | TSL:1 MANE Select | c.1447G>T | p.Glu483* | stop_gained | Exon 8 of 8 | ENSP00000216124.5 | ||
| ARSA | ENST00000356098.9 | TSL:1 | c.1447G>T | p.Glu483* | stop_gained | Exon 9 of 9 | ENSP00000348406.5 | ||
| ARSA | ENST00000395619.3 | TSL:5 | c.1447G>T | p.Glu483* | stop_gained | Exon 9 of 9 | ENSP00000378981.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000123 AC: 3AN: 244416 AF XY: 0.00000750 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1457332Hom.: 0 Cov.: 32 AF XY: 0.00000414 AC XY: 3AN XY: 724614 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Metachromatic leukodystrophy Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ARSA protein in which other variant(s) (p.Cys495Phe) have been determined to be pathogenic (PMID: 19021637). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 941799). This variant has not been reported in the literature in individuals affected with ARSA-related conditions. This variant is present in population databases (rs148352371, gnomAD 0.009%). This sequence change creates a premature translational stop signal (p.Glu483*) in the ARSA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 27 amino acid(s) of the ARSA protein.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at